The C. difficile Relapse Rate is Low in IBD Patients Who Have Metronidazole or Vancomycin as Initial Therapy

Autor:	Amar S. Naik, Amar Dodda, Yelena Zadvornova, Kathleen Idstein, Kari Best, Lilani P. Perera, Benson T. Massey, Daniel J. Stein
Rok vydání:	2014
Předmět:	medicine.medical_specialty Hepatology business.industry Gastroenterology Relapse rate C difficile Metronidazole Internal medicine medicine Vancomycin business Initial therapy medicine.drug
Zdroj:	American Journal of Gastroenterology. 109:S494
ISSN:	0002-9270
DOI:	10.14309/00000434-201410002-01666
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::63548d31d3ba39ad6bd4c2bd902e26e0 https://doi.org/10.14309/00000434-201410002-01666 Zobrazit plný text záznamu